Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.53
+0.16 (1.91%)
At close: Mar 25, 2026, 4:00 PM EDT
8.61
+0.08 (0.94%)
After-hours: Mar 25, 2026, 6:02 PM EDT
Xilio Therapeutics Employees
Xilio Therapeutics had 64 employees as of December 31, 2024. The number of employees decreased by 9 or -12.33% compared to the previous year.
Employees
64
Change
-9
Growth
-12.33%
Revenue / Employee
$683,844
Profits / Employee
-$547,438
Market Cap
49.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Mar 31, 2024 | 56 | -33 | -37.08% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Sep 30, 2023 | 81 | -8 | -8.99% |
| Jun 30, 2023 | 84 | 6 | 7.69% |
| Mar 31, 2023 | 89 | 11 | 14.10% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Mar 31, 2022 | 78 | 21 | 36.84% |
| Dec 31, 2021 | 74 | 17 | 29.82% |
| Sep 30, 2021 | 69 | - | - |
| Jun 30, 2021 | 66 | - | - |
| Mar 31, 2021 | 57 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kezar Life Sciences | 55 |
| Lisata Therapeutics | 26 |
| MiNK Therapeutics | 23 |
| Plus Therapeutics | 21 |
| GeoVax Labs | 17 |
| Atossa Therapeutics | 15 |
| Rallybio | 15 |
| Nutriband | 13 |
XLO News
- 2 days ago - Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 8 days ago - Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 13 days ago - Xilio Therapeutics Announces 1-for-14 Reverse Stock Split - GlobeNewsWire
- 23 days ago - Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 23 days ago - Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Xilio Therapeutics Announces Pricing of Underwritten Offering - GlobeNewsWire
- 2 months ago - Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates - GlobeNewsWire
- 4 months ago - Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results - GlobeNewsWire